News and features

Articles

Showing 361 - 370 of 1261

News & Analysis

RS Helikopter GmbH AnJie Broad assisted Rode Helicopter in its wholly-owned acquisition of a German coaxial twin-rotor helicopter R&D and manufacturing enterprise RS Helikopter GmbH

08 January 2024 by AnJie Broad Law Firm

RS Helikopter GmbH AnJie Broad assisted Rode Helicopter in its wholly-owned acquisition of a German coaxial twin-rotor helicopter R&D and manufacturing enterprise RS Helikopter GmbH

News & Analysis

RS Helikopter GmbH AnJie Broad assisted Rode Helicopter in its wholly-owned acquisition of a German coaxial twin-rotor helicopter R&D and manufacturing enterprise RS Helikopter GmbH

08 January 2024 by AnJie Broad Law Firm

RS Helikopter GmbH AnJie Broad assisted Rode Helicopter in its wholly-owned acquisition of a German coaxial twin-rotor helicopter R&D and manufacturing enterprise RS Helikopter GmbH

News & Analysis

First Insights into China’s New Corporate Landscape

05 January 2024 by Ray SHI, Claire XU

Barely a week ago on December 29, 2023, China’s legislative body passed and President Xi Jinping signed into law the newly revised Company Law, effective from July 1, 2024 (the “New Law”).

News & Analysis

First Insights into China’s New Corporate Landscape

05 January 2024 by Ray SHI, Claire XU

Barely a week ago on December 29, 2023, China’s legislative body passed and President Xi Jinping signed into law the newly revised Company Law, effective from July 1, 2024 (the “New Law”).

News & Analysis

Anatomy of Licensing Deals from China Regulatory Perspective

04 January 2024 by Aaron GU, Pengfei YOU, Duzhiyun ZHENG, Yuzhen ZHANG, Fengqi YU

Driven by the passion and belief, and fraught with various risks and challenges, the research and development of innovative drugs and medical devices is a journey that’s never easy.

News & Analysis

Anatomy of Licensing Deals from China Regulatory Perspective

04 January 2024 by Aaron GU, Pengfei YOU, Duzhiyun ZHENG, Yuzhen ZHANG, Fengqi YU

Driven by the passion and belief, and fraught with various risks and challenges, the research and development of innovative drugs and medical devices is a journey that’s never easy.

News & Analysis

ESG Banking Products in China — (I) Green Deposits

03 January 2024 by Ting ZHENG, Raymond YAN, Eryin YING, Lin ZHU

ESG is in high alignment with China’s “dual carbon” goals and has become an important indicator for measuring the sustainable and high-quality development of enterprises in China

News & Analysis

ESG Banking Products in China — (I) Green Deposits

03 January 2024 by Ting ZHENG, Raymond YAN, Eryin YING, Lin ZHU

ESG is in high alignment with China’s “dual carbon” goals and has become an important indicator for measuring the sustainable and high-quality development of enterprises in China

News & Analysis

Foreign Acquisition of Chinese State-Owned Enterprises

03 January 2024 by Hui Ye Law Firm - China

Wu Dong and Sun Xiaoning from Hui Ye Law Firm highlight a number of considerations that warrant particular attention from foreign investors seeking to acquire state-owned enterprises in China.

News & Analysis

Foreign Acquisition of Chinese State-Owned Enterprises

03 January 2024 by Hui Ye Law Firm - China

Wu Dong and Sun Xiaoning from Hui Ye Law Firm highlight a number of considerations that warrant particular attention from foreign investors seeking to acquire state-owned enterprises in China.